Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 106
interventional 71
Observational 29
Registry 6

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 18
Device 15
Behavioral 11
Drug|Other 6
Drug|Procedure 5
Other 5
Procedure 5
Behavioral|Other 2
Diagnostic Test 2
Device|Other 1
Drug|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 26
France 4
India 4
NA 3
United Kingdom 3
Canada 2
China 2
Spain 2
Australia|Belgium|Canada|France|Germany|Greece|Hungary|Italy|Netherlands|Spain|Switzerland|Turkey|United Kingdom 1
Austria|Australia|Canada|Czech Republic|Denmark|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Austria|Canada|France|Germany|Hong Kong|Hungary|India|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Poland|Portugal|Singapore|Slovakia|Spain|Switzerland|Turkey|United Kingdom 1
Belgium|Czech Republic|France|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
Belgium|Netherlands 1
Brazil 1
Bulgaria|Belgium|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Korea, Republic of|Latvia|Lebanon|Lithuania|Malaysia|Norway|Poland|Russian Federation|Singapore|Slovakia|Sweden|Switzerland|Taiwan|Turkey 1
China|Hong Kong|India|Korea, Republic of|Philippines|Thailand 1
China|Hong Kong|Japan|Korea, Republic of|Singapore|Taiwan 1
Czech Republic|Germany|Hungary|Poland|United Kingdom 1
Denmark 1
Egypt 1
Finland 1
Germany|Hungary|Poland|United Kingdom 1
Iran, Islamic Republic of 1
Israel 1
Italy 1
Italy|United States|Argentina|Australia|Austria|Canada|Colombia|Israel|Japan|Netherlands|Portugal|Puerto Rico|Spain|United Kingdom 1
Mexico 1
Slovakia|United States|Hungary|Israel|Puerto Rico 1
Switzerland 1
United States|Austria|Canada|China|Denmark|France|Germany|Hong Kong|Israel|Italy|Japan|Puerto Rico|Russian Federation|Slovakia|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Belgium 1
United States|Belgium|Canada|France 1
United States|Belgium|Canada|France|Germany|Netherlands|United Kingdom 1

Sites per Study

Site_count Study_Count
1 42
2 2
3 3
4 2
5 1
6 1
7 1
11 1
13 2
17 2
28 1
31 1
35 1
43 1
47 1
64 1
66 1
68 1
74 1
78 1
80 1
99 1
100 1
123 1

Phase

Phase Study_Count
N/A 43
Phase 3 15
Phase 1/Phase 2 4
Phase 4 4
Phase 2 3
Phase 1 1
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 15
2 39
3 10
4 3
5 2
NA 2

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00 30 11.00 20.00000 30 200.0000 20
1st Qu. 30.00 30 16.25 51.50000 30 311.0000 32
Median 57.00 30 18.00 83.00000 30 373.0000 131
Mean 23359.98 30 20.50 75.33333 30 568.7333 169
3rd Qu. 125.50 30 22.25 103.00000 30 478.5000 268
Max. 1000000.00 30 35.00 123.00000 30 3300.0000 394

Trial Group Type

group_type Group_Count
Experimental 85
Active Comparator 38
Other 8
No Intervention 6
Sham Comparator 6
Placebo Comparator 2
NA 2

Intervention Model

intervention_model Study_Count
Parallel Assignment 44
Single Group Assignment 16
Crossover Assignment 8
Sequential Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 41
Prevention 9
Other 6
Diagnostic 5
Basic Science 3
Health Services Research 3
Screening 2
Supportive Care 2

Observational Studies

Studies by Country

Country Study_Count
United States 9
France 5
China 2
Germany 2
NA 2
Canada 1
Israel 1
Norway 1
Spain 1
Sweden 1
Switzerland 1
Turkey 1
United Kingdom 1
United States|France|Germany|Netherlands 1

Sites per Study

Site_count Study_Count
1 25
2 2
7 1
24 1

Enrollment Metrics

Measure Observational
Min 19.0000
1st Qu 60.0000
Median 141.0000
Mean 644.7241
3rd Qu 344.0000
Max 5778.0000

Observation Model

observational_model Study_Count
Cohort 14
Other 5
Case-Control 4
Case Control 3
Case-Only 1
Ecologic or Community 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 19
Cross-Sectional 6
Retrospective 3
NA 1

Registries

Studies by Country

Country Study_Count
NA 2
Belgium 1
China 1
Germany 1
United States 1

Sites per Study

Site_count Study_Count
1 6

Enrollment Metrics

Measure Registries
Min 30.0
1st Qu 30.0
Median 40.0
Mean 990489.8
3rd Qu 1887.5
Max 5940299.0

Registry Model

observational_model Study_Count
Cohort 3
Case-Only 2
Other 1

Time Perspective

time_perspective Study_Count
Prospective 4
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
1 Day 1
1 Week 1
10 Years 1
17 Years 1
180 Days 1
2 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03368027 Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa https://ClinicalTrials.gov/show/NCT03368027 Completed Universidad de Granada 2018-12-03
NCT03264885 Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme https://ClinicalTrials.gov/show/NCT03264885 Completed Singapore National Eye Centre 2017-01-01
NCT03212222 Cell Phone Application for Vision Assessment https://ClinicalTrials.gov/show/NCT03212222 Completed Duke University 2017-12-15
NCT03207477 Premavision Cohort Follow-up https://ClinicalTrials.gov/show/NCT03207477 Active, not recruiting Central Hospital, Nancy, France 2020-06-30
NCT03192722 Low Vision Patients’ Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2 https://ClinicalTrials.gov/show/NCT03192722 Recruiting Nova Southeastern University 2020-12-31
NCT03174314 Feasibility and Efficacy of Assisstive Tactile and Auditory Communicating Devices https://ClinicalTrials.gov/show/NCT03174314 Recruiting NYU Langone Health 2021-12-31
NCT02911805 Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation https://ClinicalTrials.gov/show/NCT02911805 Active, not recruiting VA Office of Research and Development 2020-03-29
NCT02680223 Efficacy of Coloured Overlays and Lenses for Reading Difficulty https://ClinicalTrials.gov/show/NCT02680223 Completed City, University of London 2019-12-31
NCT02679313 Effect of Lens Presentation on the Clinical Oculomotor Assessment at Near https://ClinicalTrials.gov/show/NCT02679313 Completed State University of New York College of Optometry 2016-09-30
NCT02669095 Clinical Evaluation of Approved and Investigational Contact Lenses https://ClinicalTrials.gov/show/NCT02669095 Completed Johnson & Johnson Vision Care, Inc. 2016-03-31
NCT02625233 Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses https://ClinicalTrials.gov/show/NCT02625233 Completed Johnson & Johnson Vision Care, Inc. 2016-02-01
NCT02607384 The Baltimore Reading and Eye Disease Study https://ClinicalTrials.gov/show/NCT02607384 Completed Johns Hopkins University 2016-07-31
NCT02595502 Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses https://ClinicalTrials.gov/show/NCT02595502 Completed Johnson & Johnson Vision Care, Inc. 2015-11-01
NCT03403959 Seasonal Affective Disorder and Visual Impairment https://ClinicalTrials.gov/show/NCT03403959 Recruiting Psychiatric Centre Rigshospitalet 2020-03-01
NCT02543528 A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One Week https://ClinicalTrials.gov/show/NCT02543528 Completed Johnson & Johnson Vision Care, Inc. 2016-11-08
NCT02540122 Pilot Clinical Evaluation of Approved Contact Lenses https://ClinicalTrials.gov/show/NCT02540122 Completed Johnson & Johnson Vision Care, Inc. 2016-06-30
NCT02391961 Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis https://ClinicalTrials.gov/show/NCT02391961 Completed VA Office of Research and Development 2019-01-31
NCT02259088 A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients https://ClinicalTrials.gov/show/NCT02259088 Completed Novartis 2017-01-17
NCT02258113 Measuring of Neuro-visual Functionality With Ocusweep https://ClinicalTrials.gov/show/NCT02258113 Recruiting Ocuspecto Oy 2021-12-31
NCT02102958 Nonvisual Foot Examination for People With Diabetes and Visual Impairment https://ClinicalTrials.gov/show/NCT02102958 Completed Case Western Reserve University 2013-12-31
NCT01315275 A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema https://ClinicalTrials.gov/show/NCT01315275 Completed Novartis 2012-08-31
NCT02034006 A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. https://ClinicalTrials.gov/show/NCT02034006 Completed Novartis 2016-07-15
NCT01922102 Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia https://ClinicalTrials.gov/show/NCT01922102 Completed Novartis 2016-09-14
NCT01822717 Nonvisual Foot Inspection for People With Visual Imapirment https://ClinicalTrials.gov/show/NCT01822717 Completed Case Western Reserve University 2012-09-30
NCT01816087 Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians https://ClinicalTrials.gov/show/NCT01816087 Completed University of Lausanne 2014-11-30
NCT01701700 The Effectiveness of Portable Electronic Vision Enhancement Systems (p-EVES) for Near Vision in Visual Impairment https://ClinicalTrials.gov/show/NCT01701700 Completed Manchester University NHS Foundation Trust 2015-04-30
NCT01698788 Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698788 Completed Postgraduate Institute of Medical Education and Research 2011-12-31
NCT01698749 Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698749 Completed Postgraduate Institute of Medical Education and Research 2012-01-31
NCT01691027 Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas https://ClinicalTrials.gov/show/NCT01691027 Completed VA Office of Research and Development 2015-07-31
NCT01546402 Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01546402 Completed Postgraduate Institute of Medical Education and Research 2012-11-30
NCT01535261 Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01535261 Completed Novartis 2015-03-31
NCT01396083 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01396083 Completed Novartis 2014-01-31
NCT01396057 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) https://ClinicalTrials.gov/show/NCT01396057 Completed Novartis 2013-06-30
NCT01366677 Yoga for Persons With Severe Visual Impairment https://ClinicalTrials.gov/show/NCT01366677 Completed Johns Hopkins University 2013-12-31
NCT04158622 Retinal Displacement Rates in Pneumatic Retinopexy Versus Pars Plana Vitrectomy For Primary Retinal Detachment https://ClinicalTrials.gov/show/NCT04158622 Recruiting St. Michael’s Hospital, Toronto 2021-12-31
NCT04143620 Triple Procedure for Dense Cataractus Neovascular Glaucoma Patients https://ClinicalTrials.gov/show/NCT04143620 Completed Minia University 2019-08-31
NCT04141891 Advancing Understanding of Transportation Options https://ClinicalTrials.gov/show/NCT04141891 Recruiting University of Colorado, Denver 2023-08-01
NCT04123626 A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene https://ClinicalTrials.gov/show/NCT04123626 Recruiting ProQR Therapeutics 2021-10-07
NCT04074642 OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. https://ClinicalTrials.gov/show/NCT04074642 Recruiting Centre Hospitalier Universitaire de Nice 2020-07-31
NCT04035343 Effect of Type of Head Positioning on Retinal Displacement in Vitrectomy for Retinal Detachment https://ClinicalTrials.gov/show/NCT04035343 Recruiting St. Michael’s Hospital, Toronto 2020-10-31
NCT03957980 Remote Access: Cortical Visual Impairment https://ClinicalTrials.gov/show/NCT03957980 Completed Children’s Hospital Medical Center, Cincinnati 2018-11-13
NCT03922347 mHealth Intervention for Improving Eye Health at Community Level https://ClinicalTrials.gov/show/NCT03922347 Completed Shahid Beheshti University of Medical Sciences 2018-05-15
NCT03917472 Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03917472 Active, not recruiting Novartis 2021-07-30
NCT03913143 A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) https://ClinicalTrials.gov/show/NCT03913143 Recruiting ProQR Therapeutics 2020-12-31
NCT03913130 Extension Study to Study PQ-110-001 (NCT03140969) https://ClinicalTrials.gov/show/NCT03913130 Active, not recruiting ProQR Therapeutics 2021-03-31
NCT03872479 Single Ascending Dose Study in Participants With LCA10 https://ClinicalTrials.gov/show/NCT03872479 Recruiting Allergan 2024-03-22
NCT03811366 Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I https://ClinicalTrials.gov/show/NCT03811366 Completed University of Sao Paulo 2017-01-31
NCT03802630 Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03802630 Recruiting Novartis 2023-05-26
NCT03781583 SmartHMD for Improved Mobility https://ClinicalTrials.gov/show/NCT03781583 Recruiting University of Michigan 2021-03-31
NCT03780257 Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene https://ClinicalTrials.gov/show/NCT03780257 Recruiting ProQR Therapeutics 2021-12-31
NCT03763721 The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation https://ClinicalTrials.gov/show/NCT03763721 Recruiting UMC Utrecht 2021-05-31
NCT03640130 Peripheral Reading https://ClinicalTrials.gov/show/NCT03640130 Enrolling by invitation University of Houston 2019-03-01
NCT03592615 Binocular Vision Anomalies After Cataract and Refractive Surgery https://ClinicalTrials.gov/show/NCT03592615 Completed Salus University 2019-11-26
NCT03560765 Mobile Electronic Devices for Visual Impairment https://ClinicalTrials.gov/show/NCT03560765 Recruiting University of Manchester 2020-07-01
NCT03481660 A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481660 Active, not recruiting Novartis 2020-07-15
NCT03481634 Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481634 Active, not recruiting Novartis 2020-11-11
NCT03473431 Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment. https://ClinicalTrials.gov/show/NCT03473431 Completed Instituto Mexicano del Seguro Social 2018-06-30
NCT03455478 Shanghai Eye Study for Older People https://ClinicalTrials.gov/show/NCT03455478 Recruiting Shanghai Eye Disease Prevention and Treatment Center 2018-11-30
NCT01250210 Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control https://ClinicalTrials.gov/show/NCT01250210 Completed Agile Therapeutics 2008-02-29
NCT01217944 Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia https://ClinicalTrials.gov/show/NCT01217944 Completed Novartis 2012-08-31
NCT01171976 Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01171976 Completed Novartis 2013-04-30
NCT01103206 Evaluation of a Cincalcet Suppression Test https://ClinicalTrials.gov/show/NCT01103206 Completed University Hospital, Rouen 2013-02-28
NCT00989989 Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00989989 Completed Novartis 2011-08-31
NCT00985231 Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers https://ClinicalTrials.gov/show/NCT00985231 Completed Bausch & Lomb Incorporated 2009-11-30
NCT00901186 Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00901186 Completed Novartis 2012-08-31
NCT00827632 Obesity, Oral Contraception, and Ovarian Suppression https://ClinicalTrials.gov/show/NCT00827632 Completed Columbia University 2008-12-31
NCT03571841 Sexual Health and Rehabilitation After Ovarian Suppression Treatment https://ClinicalTrials.gov/show/NCT03571841 Completed Dana-Farber Cancer Institute 2019-12-01
NCT03141164 Peripheral Vision Training Study https://ClinicalTrials.gov/show/NCT03141164 Recruiting University of Alabama at Birmingham 2020-09-30
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study https://ClinicalTrials.gov/show/NCT00687804 Completed Novartis 2010-01-31
NCT00395122 Optical Coherence Tomography Measurements in Eyes With Band Atrophy https://ClinicalTrials.gov/show/NCT00395122 Completed University of Sao Paulo NA
NCT00342108 Cortical Visual Impairment and Visual Attentiveness https://ClinicalTrials.gov/show/NCT00342108 Completed Sheba Medical Center 2009-07-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03396042 Natural History Study of CEP290-Related Retinal Degeneration https://ClinicalTrials.gov/show/NCT03396042 Recruiting Allergan 2020-12-31
NCT03187613 Correlation of Metamorphopsia and Aniseikonia to Retinal Shift Following Retinal Detachment Surgery https://ClinicalTrials.gov/show/NCT03187613 Active, not recruiting Helse Stavanger HF 2021-01-31
NCT03169855 Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability https://ClinicalTrials.gov/show/NCT03169855 Completed Aalen University 2018-12-31
NCT02896738 MRI Screening for Auditory Pathway Malformations in Visually Impaired Children https://ClinicalTrials.gov/show/NCT02896738 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-03-09
NCT02862405 Perception of Objects and Natural Scenes in People With Vision Loss (ACTIVIS) https://ClinicalTrials.gov/show/NCT02862405 Completed Lille Catholic University 2015-03-31
NCT02571647 Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory https://ClinicalTrials.gov/show/NCT02571647 Completed Nantes University Hospital 2017-04-24
NCT02485054 A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO) https://ClinicalTrials.gov/show/NCT02485054 Completed Fondation Ophtalmologique Adolphe de Rothschild 2018-10-31
NCT02194803 Observation of Treatment Patterns With Lucentis in Approved Indications https://ClinicalTrials.gov/show/NCT02194803 Completed Novartis 2016-12-31
NCT01632787 Utility of a Survey Instrument to Predict Benefit From a Novel Treatment for Vertical Heterophoria https://ClinicalTrials.gov/show/NCT01632787 Completed Vision Specialists of Birmingham 2016-04-30
NCT04391166 Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic https://ClinicalTrials.gov/show/NCT04391166 Recruiting Vanderbilt University Medical Center 2022-05-01
NCT04249505 Refractive Accuracy of “2WIN” and Portable Autorefractors https://ClinicalTrials.gov/show/NCT04249505 Recruiting Alaska Blind Child Discovery 2020-03-31
NCT04237350 Video Screening for Visual Impairment of Infants https://ClinicalTrials.gov/show/NCT04237350 Recruiting Sun Yat-sen University 2020-06-30
NCT04190147 Eye and Growth in Adolescents Born Moderate-to-late Preterm https://ClinicalTrials.gov/show/NCT04190147 Enrolling by invitation Vastra Gotaland Region 2020-06-01
NCT04143334 Prevalence of Blindness, Visual Impairment in Chao Nan Area, China https://ClinicalTrials.gov/show/NCT04143334 Completed Chinese University of Hong Kong 2015-12-01
NCT04112524 Comparison of Quantitative Metamorphopsia- Measurements in Patients With mCNV https://ClinicalTrials.gov/show/NCT04112524 Recruiting Vista Klinik 2020-10-31
NCT04089033 Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN) https://ClinicalTrials.gov/show/NCT04089033 Recruiting St. Michael’s Hospital, Toronto 2020-05-31
NCT03889444 Chart Review: Drug Utilization Study in Participants Who Received Ozurdexâ„¢ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03889444 Completed Allergan 2019-06-07
NCT03865134 Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity https://ClinicalTrials.gov/show/NCT03865134 Completed Istanbul Medipol University Hospital 2019-03-25
NCT03860727 Comparison of Ophthalmoscopy Findings Using PanOptic vs PanOptic + iExaminer https://ClinicalTrials.gov/show/NCT03860727 Recruiting State University of New York at Buffalo 2019-05-07
NCT03767803 Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women https://ClinicalTrials.gov/show/NCT03767803 Active, not recruiting Progenity, Inc. 2020-12-31
NCT03603301 Vision in Children Born to Opioid-dependent Methadone-maintained Mothers https://ClinicalTrials.gov/show/NCT03603301 Enrolling by invitation NHS Greater Glasgow and Clyde 2019-02-28
NCT02651389 Evaluation of Tests Performance on a New Digital Orthoptic Platform https://ClinicalTrials.gov/show/NCT02651389 Completed University Hospital, Brest 2016-09-29
NCT03431207 Behavioral Dynamics Between Infants With Visual Loss and Healthy Controls https://ClinicalTrials.gov/show/NCT03431207 Completed Sun Yat-sen University 2017-10-31
NCT01209507 Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy https://ClinicalTrials.gov/show/NCT01209507 Completed University of Colorado, Denver 2015-11-30
NCT04277754 Motor and Visual Development in 2 Year Olds https://ClinicalTrials.gov/show/NCT04277754 Recruiting University of Seville 2020-02-20
NCT00671450 Visual Dysfunction in Mild Traumatic Brain Injury (MTBI): A Comparison Group Study https://ClinicalTrials.gov/show/NCT00671450 Completed VA Office of Research and Development 2009-07-31
NCT00650676 The Effect of Somatosensory Cue on Postural Stability in Blinded Persons https://ClinicalTrials.gov/show/NCT00650676 Completed Soroka University Medical Center 2009-03-31
NCT00555113 Evolution of Visual Impairment During Pseudoxanthoma Elasticum https://ClinicalTrials.gov/show/NCT00555113 Completed European Georges Pompidou Hospital NA
NCT00013936 A Novel Acuity Testing Method https://ClinicalTrials.gov/show/NCT00013936 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03045367 Mid-term Evaluation of Metamorphopsia in Epiretinal Membrane Surgery https://ClinicalTrials.gov/show/NCT03045367 Completed Clinica Oculistica dell’Università di Torino 2016-10-31
NCT04347564 Usability of a Software for the Categorisation of Metamorphopsia https://ClinicalTrials.gov/show/NCT04347564 Recruiting Augenheilkunde Lindenthal 2020-06-30
NCT04074954 A (Prospective/Pilot) Study Evaluating the Effect of Cataract Surgery on the Daily Activity Levels of Elderly Patients https://ClinicalTrials.gov/show/NCT04074954 Recruiting University of Pikeville 2020-07-31
NCT04051983 iVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment https://ClinicalTrials.gov/show/NCT04051983 Recruiting Universitaire Ziekenhuizen Leuven 2020-10-31
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions https://ClinicalTrials.gov/show/NCT03847753 Completed University of Aarhus 2016-12-31
NCT03571217 Shanghai Beixinjing Diabetic Eyes Study https://ClinicalTrials.gov/show/NCT03571217 Recruiting Shanghai Eye Disease Prevention and Treatment Center 2024-12-31